Piper Sandler initiated coverage on Beyond Air with a new price target
$XAIR
Medical/Dental Instruments
Health Care
Piper Sandler initiated coverage of Beyond Air with a rating of Overweight and set a new price target of $10.00
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/25/2024 | Buy → Neutral | BTIG Research | |
7/28/2023 | $10.00 | Overweight | Piper Sandler |
6/15/2023 | $15.00 | Buy | BTIG Research |
11/12/2021 | $12.00 → $16.00 | Buy | Truist Securities |
For Immediate Release: July 01, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA announced a request for nominations for consumer representatives to serve on advisory committees and panels for which vacancies currently exist or are expected to occur in the near future. The FDA relies on our many advisory committees to help us